Identifying Ideas that Lead to an International IP Portfolio
Wednesday, January 24, 2024 - 4:30pm to 6:00pmInterested in how leading global product ideas begin? Want to learn about protecting intellectual property and competing in the global marketplace? Join us for a fireside chat with Kevin M. McGovern, Emeritus Member of the Board of Trustees of Cornell University and co-founder in over 25 companies. Register here.
NSF I-Corps Virtual Information Session
Tuesday, January 23, 2024 - 12:00pm to 12:45pmCalling all researchers! If you have been working on a technology innovation and wish to explore its commercialization potential, I-Corps can provide you with entrepreneurial education, mentoring, and up to $50,000 in funding for customer discovery.
Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session on Tuesday, January 23 (12:00 – 12:45 p.m. ET) is designed for busy graduate students, postdocs, and faculty interested in learning more about I-Corps regional and national programming. Laura Ray, an I-Corps instructor and Faculty Lead at Dartmouth College, along with I-Corps alum Devansh Agarwal of EchoSense, will be in attendance to share their experiences and answer questions.
The National Science Foundation created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society.
Register: https://bit.ly/ICorpsJan24
Regulatory Considerations in Cell and Gene Therapy
Tuesday, January 23, 2024 - 12:00pm to 2:00pmYou are invited to attend an informative seminar detailing regulatory considerations and updated guidelines regarding the development and commercialization of cell and gene therapies. This seminar will feature Dr. Nimi Chhina, executive director and head of Global R&D and Regulatory Policy at BioMarin Pharmaceutical, Inc. Dr. Chhina will focus on key details surrounding:
- Unique regulatory considerations for cell and gene therapy product development
- Developing and informing a regulatory strategy for your project
Attendees will have the opportunity to sign up for a 1:1 meeting to discuss their project directly with Dr. Chhina. You must register and complete the meeting request form HERE in advance. Meetings will take place directly after the program. You will receive an invitation with the suggested timeslot once Dr. Chhina has reviewed all submissions.
This event is hybrid and will take place at Weill Cornell Medicine BioVenture eLab (1157 York Ave) for in-person attendees. Register here.
Summer 2024 Prototyping Hardware Accelerator - Apply by 3/25/24
Wednesday, January 17, 2024 - 9:00am to Monday, March 25, 2024 - 11:45pmAre you an entrepreneur ready to take your product idea to the next level? Rev: Ithaca Startup Works invites you to take a deep dive into prototyping this summer!
Over 10 weeks, Rev’s Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers, and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype.
The program offers four unique tracks with tailored content and instruction which include:
- MedTech Track: Offered in partnership with Cornell Biomedical Engineering and Weill Cornell, the new MedTech track gain access to specialized prototyping equipment, regulatory resources, and research and medical professionals in the field.
Applications are now being accepted for all tracks of the Summer 2024 Prototyping Hardware Accelerator! The accelerator is held in person at Rev: Ithaca Startup Works in Ithaca, New York beginning in late May 2024. The program is free and open to the public.
Early admission deadline February 16, 2024. Applications close March 25, 2024. Apply here.
*Want to learn more? Register to attend an upcoming virtual information session:
Note: Digital platforms, applications, and other software programs are not eligible unless paired with a physical product that you intend to develop in our program.
The Mark Foundation Endeavor Awards (Deadline: 3/12/24)
Wednesday, January 3, 2024 - 9:00amThe Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.
Endeavor Awards are $3,000,000 disbursed over a 3-year term.
- The requested funding should be divided amongst team members in a manner proportional to the actual cost of the work carried out by each investigator for the project.
- The budget limit includes both direct and indirect costs, with indirect costs not to exceed 10% of the direct costs.
- The third year of funding will be contingent on sufficient scientific progress as presented at the 18-month project review.
- The letter of agreement will include IP terms with a revenue sharing component
Grants portal opens for submission of Letters of Intent (LOI) on 1/3/2024. LOI submission deadline is 3/12/2024. To learn more about the eligibility and LOI guidelines, please visit The Mark Foundation website here.
